These maladaptive effects of ANGPTL2 promote the pathogenesis of various age‐related diseases, including metabolic disorders, cardiovascular diseases, and possibly some cancers (Kadomatsu et al. 2014). Here, ANGPTL2 is linked to cardiovascular disorder.